Cargando…
Lipooxygenase inhibition in osteoarthritis: a potential symptomatic and disease modifying effect?
5-Loxin(® )is a compound extracted from an ancient herb that might be considered as a potent lipooxygenase inhibitor. The results observed in a preliminary trial suggest a highly intriguing clinically relevant symptomatic effect contrasting with a poor bioavailability of this compound. Moreover, in...
Autor principal: | Dougados, Maxime |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2592778/ https://www.ncbi.nlm.nih.gov/pubmed/18828886 http://dx.doi.org/10.1186/ar2490 |
Ejemplares similares
-
5-Lipooxygenase Derivatives as Serum Biomarkers of a Successful Dietary Intervention in Patients with NonAlcoholic Fatty Liver Disease
por: Banaszczak, Marcin, et al.
Publicado: (2020) -
Plasma Concentration of 12-Hydroxyeicosatetraenoic Acid, Single Nucleotide Polymorphisms of 12-Lipooxygenase Gene and Vaso-Occlusion in Sickle Cell Disease
por: Duru, Augustine Nwakuche, et al.
Publicado: (2021) -
Inhibition of α-Amylase, α-Glucosidase, Pancreatic Lipase, 15-Lipooxygenase and Acetylcholinesterase Modulated by Polyphenolic Compounds, Organic Acids, and Carbohydrates of Prunus domestica Fruit
por: Rybak, Martyna, et al.
Publicado: (2023) -
Functional Interaction between Acyl-CoA Synthetase 4, Lipooxygenases and Cyclooxygenase-2 in the Aggressive Phenotype of Breast Cancer Cells
por: Maloberti, Paula M., et al.
Publicado: (2010) -
First‐in‐Human Studies of Pharmacokinetics and Safety of Utreloxastat (PTC857), a Novel 15‐Lipooxygenase Inhibitor for the Treatment of Amyotrophic Lateral Sclerosis
por: Gao, Lan, et al.
Publicado: (2022)